Description

Tirzepatide

Tirzepatide vials and kits supplied as a lyophilized powder, manufactured to the highest quality standards.. Supplied in multiple variations, 5mg, 10mg, 15mg, and 30mg vial sizes.

Top: Tirzepatide molecular structure Bottom: Structure using peptide three-letter code
Clinical data
Pronunciation	/tɜːrˈzɛpətaɪd/ tur-ZEP-ə-tyde
Trade names	Mounjaro, Zepbound
Other names	LY3298176
AHFS/Drugs.com	Monograph
MedlinePlus	a622044
License data	US DailyMed: Tirzepatide
Pregnancy category	AU: D[1]
Routes of administration	Subcutaneous
Drug class	Antidiabetic, GLP-1 receptor agonist
ATC code	A10BX16 (WHO)
Legal status
Legal status	AU: S4 (Prescription only)[1][2][3][4] CA: ℞-only[5][6][7] UK: POM (Prescription only)[8] US: ℞-only[9][10] EU: Rx-only[11]
Pharmacokinetic data
Bioavailability	80%
Protein binding	Albumin
Metabolism	Proteolytic cleavage, β-oxidation of fatty diacid section and amide hydrolysis
Elimination half-life	5 days
Excretion	Urine and feces
Identifiers
IUPAC name
CAS Number	2023788-19-2
PubChem CID	166567236
IUPHAR/BPS	11429
DrugBank	DB15171
ChemSpider	76714503
UNII	OYN3CCI6QE
KEGG	D11360
ChEBI	CHEBI:194186
ChEMBL	ChEMBL4297839
ECHA InfoCard	100.369.612
Chemical and physical data
Formula	C225H348N48O68
Molar mass	4813.527 g·mol−1
SMILES
InChI